Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/03/22
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 12/31/23
End: 04/30/26
Due: 04/30/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| ASC618 Gene Therapy in Hemophilia A Patients | NCT04676048 | ASC Therapeutics | user2@example.com | None | 2022-08-03 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |
| ASC930 in Patients With Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD) | NCT04883918 | ASC Therapeutics | user2@example.com | None | 2023-12-31 | 2026-04-30 | 2027-04-30 | - | - | 2025-07-14 |